Malcolm Brenner
Pediatrics / Pediatric Hematology-Oncology
Credentials: · · ·
History
- 1980–1983
Chelsea & Westminster Hospital
- 1977–1980
Medical Registrar
- 1976–1977
- 1975–1976
- 1971–1975
CAMBRIDGE UNIV, CAMBRIDGE
Research
Nature Medicine · 1999 · Last of 11 authors · 1,401 citations
Inducible apoptosis as a safety switch for adoptive cell therapy
New England Journal of Medicine · 2011 · Last of 20 authors · 1,281 citations
A distinct "side population" of cells with high drug efflux capacity in human tumor cells
Proceedings of the National Academy of Sciences of the United States of America · 2004 · Last of 8 authors · 1,032 citations
225 papers · 36 as a fellow
53 papers · 3 as a fellow
47 papers
38 papers
28 papers · 1 as a fellow
- KL
19 papers
17 papers
15 papers · 1 as a fellow
Grants
- 2003–2028
Training In Cell and Gene Therapy
National Heart, Lung, and Blood Institute · T32
PI · $2.1M · Baylor College of Medicine
- 2007–2027
- 2002–2018
Enhancing t Cell Therapy of Cancer
National Cancer Institute · P01
Project lead · $1.7M · Baylor College of Medicine
- 2010–2015
Baylor College of Medicine Cancer Center - Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $119.1K · Baylor College of Medicine
Clinical trials
- 2013–2015
Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide
Principal investigator · Terminated · Phase 1
Baylor College of Medicine
- 2011–2029
Administration of Donor T Cells With the Caspase-9 Suicide Gene
Principal investigator · Active not recruiting · Phase 1
Baylor College of Medicine
- 2010–2026
Principal investigator · Active not recruiting · Phase 1, Phase 2
Baylor College of Medicine
- 2008–2027
CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene
Principal investigator · Active not recruiting · Phase 1
Baylor College of Medicine